日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Inhibiting the pathological changes of PASMCs is an effective approach for medicinal plants or secondary metabolites in treating pulmonary hypertension

抑制肺动脉平滑肌细胞（PASMCs）的病理变化是药用植物或次生代谢产物治疗肺动脉高压的有效途径。

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2026.1725809
Liang, Qi; Gou, Hanghang; Zhu, Yi; He, Lin; Chen, Liping; Zhang, Chuantao; Ai, Li
肺动脉高压
细胞生物学
心血管
代谢
发表日期：2026
文献求助 收藏

Life's Essential 8 and cardiovascular health: Protective effects on chronic respiratory diseases

生命必需的8种营养素与心血管健康：对慢性呼吸系统疾病的保护作用

期刊:International Journal of Cardiology Cardiovascular Risk and Prevention
影响因子:2.1
doi:10.1016/j.ijcrp.2025.200567
Ma, Jianli; Cao, Xiyu; Ma, Zhipeng; Liu, Xiao; Wang, Hualing; Liu, Ke; Li, Xinyu; Zhang, Chuantao
呼吸系统疾病
发表日期：2026
文献求助 收藏

Responsive ROS-Augmented Prodrug Hybridization Nanoassemblies for Multidimensionally Synergitic Treatment of Hepatocellular Carcinoma in Cascade Assaults

响应型ROS增强型前药杂交纳米组装体用于级联攻击中肝细胞癌的多维协同治疗

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202501420
Zeng, Yingjie; Cao, Yuening; Ren, Senmiao; Zhang, Chaozheng; Liu, Jianan; Liu, Ke; Wang, Yan; Chen, Hongyu; Zhou, Fengjiao; Yang, Xiuli; Ge, Xian; Zhang, Tingting; Wang, Tianbao; He, Yao; Li, Defang; Zhang, Chuantao; Lu, Jun
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Hybridization-based discovery of novel quinazoline-2-indolinone derivatives as potent and selective PI3Kα inhibitors

基于杂交技术的新型喹唑啉-2-吲哚啉酮衍生物作为高效选择性PI3Kα抑制剂的发现

期刊:Journal of Advanced Research
影响因子:13
doi:10.1016/j.jare.2024.03.002
Liu, Changqun; Cao, Yuening; Zuo, Yi; Zhang, Chaozheng; Ren, Senmiao; Zhang, Xin; Wang, Chuanqi; Zeng, Yingjie; Ling, Jie; Liu, Yilan; Chen, Zixian; Cao, Xiujun; Wu, Zhengzhi; Zhang, Chuantao; Lu, Jun
发表日期：2025
文献求助 收藏

Combination therapy with Chicoric acid and PD-1/PD-L1 blockade improves the immunotherapy response in patient-derived ovarian cancer xenograft model.

菊苣酸与 PD-1/PD-L1 阻断剂联合治疗可改善患者来源卵巢癌异种移植模型的免疫治疗反应

期刊:Cell Communication and Signaling
影响因子:8.9
doi:10.1186/s12964-025-02146-7
Lan Hongwei, Zhu Jingjuan, Hou Helei, Zhang Chuantao, Huo Xingfa, Zhang Yuming, Yang Fangfang, Zhou Na, Zhang Xiaochun
免疫/内分泌
卵巢癌
发表日期：2025
文献求助 收藏

Computational toxicology in drug discovery: applications of artificial intelligence in ADMET and toxicity prediction

药物发现中的计算毒理学：人工智能在ADMET和毒性预测中的应用

期刊:Briefings in Bioinformatics
影响因子:7.7
doi:10.1093/bib/bbaf533
Zhang, Jiangyan; Li, Haolin; Zhang, Yuncong; Huang, Junyang; Ren, Liping; Zhang, Chuantao; Zou, Quan; Zhang, Yang
毒理研究
MET
发表日期：2025
文献求助 收藏

Additions of trastuzumab to preoperative chemotherapy or chemoimmunotherapy for patients with potentially resectable stage III to IV(B) HER2-positive gastric cancer

对于潜在可切除的III期至IV(B)期HER2阳性胃癌患者，在术前化疗或化疗免疫疗法中加入曲妥珠单抗治疗

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1624943
Zhang, Xuchen; Tian, Yulong; Wang, Huiyun; Song, Shanai; Chen, Yunqing; Liu, Ning; Zhang, Chuantao; Huang, Xiao; Jiang, Haitao; Hou, Helei
胃癌
肿瘤
肿瘤免疫
HER2
免疫/内分泌
发表日期：2025
文献求助 收藏

Combination of anlotinib with immunotherapy enhanced both anti-angiogenesis and immune response in high-grade serous ovarian cancer.

安罗替尼联合免疫疗法可增强高级别浆液性卵巢癌的抗血管生成和免疫反应

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1539616
Lan Hongwei, Liu Hui, Hou Helei, Zhang Chuantao, Zhu Jingjuan, Zhou Na, Zhang Xiaochun
心血管
卵巢癌
血管生成
发表日期：2025
文献求助 收藏

Advances in Jellyfish Sting Mechanisms and Treatment Strategies

水母蜇伤机制和治疗策略的研究进展

期刊:Marine Drugs
影响因子:5.4
doi:10.3390/md23060231
Li, Bingbing; Li, Yueyue; Qiu, Zhiwen; Zhang, Chuantao; Li, Yue; Li, Wei; Yang, Jishun
发表日期：2025
文献求助 收藏

Curcumin mediates oxidative stress to play an anti-fibrotic role, focusing on liver, renal, myocardial and pulmonary fibrosis

姜黄素通过调节氧化应激发挥抗纤维化作用，主要针对肝脏、肾脏、心肌和肺部纤维化。

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1636538
Yu, Shishuang; Pu, Jufang; Liu, Ke; He, Cuifang; Yang, Feifei; Chen, Ke; Yang, Xiuli; Zhu, Yi; Jiang, Jun; Luo, Maocai; Liu, Xiao; Zhang, Chuantao; He, Yujiao
毒理研究
氧化应激
发表日期：2025
文献求助 收藏